China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia Dec 02, 2024 22:30 JST Read More
Honda Introduces AI-powered Social Robot, Haru, to University Hospital in Spain Dec 02, 2024 22:08 HKT/SGT Read More
China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia Dec 02, 2024 21:30 HKT/SGT Read More
NTT and Olympus Joint Demonstration Shows IOWN APN's Low-latency Capability Can Be Used for Real-time Diagnosis and Treatment on a Remote Server to Realize World's First Cloud Endoscopy System Nov 19, 2024 14:30 HKT/SGT Read More
Predictive Heart Monitoring Startup, GPx, Secures New Investment From NEC X; Joins Elev X! Boost Venture Studio Program Nov 13, 2024 11:05 HKT/SGT Read More
China Medical System: First Ruxolitinib Cream's Prescriptions for Vitiligo Issued in the Greater Bay Area Oct 21, 2024 10:00 HKT/SGT Read More
China Medical System: New Drug Application for Vitiligo Indication of Ruxolitinib Phosphate Cream Accepted in China Sep 24, 2024 22:00 JST Read More
China Medical System: New Drug Application for Vitiligo Indication of Ruxolitinib Phosphate Cream Accepted in China Sep 24, 2024 21:00 HKT/SGT Read More
Taiwan Excellence Pavilion concludes Medical Fair Asia 2024 with Showcase of Cutting-Edge MedTech Innovations Sep 13, 2024 17:50 HKT/SGT Read More
Taiwan Excellence Unveils Pioneering Medtech Innovation at Medical Fair Asia 2024 Sep 05, 2024 23:00 HKT/SGT Read More
Hitachi High-Tech and Gencurix entered a partnership in cancer molecular diagnostics business Aug 28, 2024 17:44 HKT/SGT Read More
Fujitsu tackles 'drug loss' in Japan through ecosystem to accelerate digitalization of clinical trials Aug 26, 2024 11:19 HKT/SGT Read More
Avantor Triumphs with Three Awards at Korea Biopharma Excellence Awards 2024 Aug 23, 2024 08:00 HKT/SGT Read More
Hitachi High-Tech Launches New Tabletop Microscopes with Enhanced Usability: TM4000PlusIII and TM4000III Aug 22, 2024 21:30 HKT/SGT Read More